Integra Lifesciences Holdings (IART) Other Non-Current Liabilities (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Other Non-Current Liabilities data on file, last reported at $195.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 21.87% year-over-year to $195.6 million; the trailing twelve-month figure through Mar 2026 stood at $195.6 million (up 21.87% YoY), and the FY2025 full-year result was $204.3 million, up 39.69% from the prior year.
• Other Non-Current Liabilities fell to $195.6 million in Q1 2026, from $204.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $253.2 million in Q2 2025 to a low of $25.0 million in Q4 2022.
• A 5-year average of $150.9 million and a median of $153.3 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities tumbled 79.21% in 2022 and jumped 699.76% in 2023, its largest moves.
• Tracing IART's Other Non-Current Liabilities over 5 years: stood at $25.0 million in 2022, then jumped by 699.76% to $199.9 million in 2023, then declined by 26.86% to $146.2 million in 2024, then jumped by 39.69% to $204.3 million in 2025, then decreased by 4.27% to $195.6 million in 2026.
• Business Quant data shows IART's Other Non-Current Liabilities at $195.6 million in Q1 2026, $204.3 million in Q4 2025, and $233.3 million in Q3 2025.